Trial · NCT01116882
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 30-day Composite Major Adverse Cardiac Event (MACE) | 30 days | |
| Primary | 12-month Composite Major Adverse Cardiac Event (MACE) | 12 month | |
| Secondary | All Cause Mortality at 30 Days | 30 days | |
| Secondary | Ischemia-driven Target Lesion Revascularization | 30 days | |
| Secondary | Ischemia-driven Target Lesion Revascularization | 12 months | |
| Secondary | Rate of Stent Thrombosis | 12 months | |
| Secondary | Any Repeat Revascularization | 12 months | |
| Secondary | Emergency or Urgent Revascularization | 30 days | |
| Secondary | Procedural Success | Post-Procedure | Procedural success is defined as residual stenosis of the target lesion of less than 20% |
| Secondary | Major Vascular Complications | 30 days | |
| Secondary | Complete Revascularization | Post-Procedure | Complete revascularization was defined as the successful treatment, according to the criteria of procedural success, of all epicardial vessels with more than 70% and less than 100% stenosis. |
| Secondary | Met Indication Criteria for PCI | Post-Procedure | Included here are the number of treated lesions that met the class I or II recommendations for anatomical indications for PCI, according to the PCI guidelines fo the American College of Cardiology Foundation-American Heart Association-Society for Cardiovascular Angiography and Interventions. |
| Secondary | All Cause Mortality at 12 Months | 12 months | |
| Secondary | Ischemia-driven Target Vessel Revascularization | 30 days | |
| Secondary | Ischemia-driven Target Vessel Revascularization | 12 months | |
| Secondary | Rate of Stent Thrombosis | 30 days | |
| Secondary | Any Repeat Revascularization | 30 days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01116882/registered